Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mitera is a private U.S. healthcare company focused on reproductive health, maternal-fetal medicine, and telehealth-enabled genetic services. The company combines patient education, physician-ordered genetic testing, at-home sample collection, reproductive genetic counseling, and follow-up consultations with maternal-fetal medicine specialists. Its commercially offered services have included at-home prenatal and carrier screening products such as Peaches&Me and 23Pears, along with surrogacy and gestational carrier screening workflows. Mitera appears positioned more as a clinical services and care-coordination platform than as a therapeutics developer, serving patients, fertility centers, surrogacy agencies, employers, and related partners. The company emphasizes medical oversight and specialist-guided interpretation in reproductive genetics and pregnancy risk management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mitera.